Mechanisms linking obesity to hypertension

Obesity‐related hypertension is increasingly recognized as a distinct hypertensive phenotype requiring a modified approach to diagnosis and management. In this review rapidly evolving insights into the complex and interdependent mechanisms linking obesity to hypertension are discussed. Overweight an...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Obesity reviews Ročník 13; číslo 1; s. 17 - 26
Hlavní autori: Dorresteijn, J. A. N, Visseren, F. L. J, Spiering, W
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Oxford, UK Blackwell Publishing Ltd 01.01.2012
Predmet:
adipocytes
Adipocytes - cytology
adipokines
adipose tissue
Antihypertensive Agents
Antihypertensive Agents - therapeutic use
blood
complications
cytology
drug therapy
drugs
etiology
free fatty acids
Health Behavior
Humans
Hypertension
Hypertension - drug therapy
Hypertension - etiology
Hypertension - prevention & control
inflammation
Life Style
lifestyle
macrophages
metabolic syndrome
obesity
Obesity - complications
obesity-related hypertension
oxidative stress
Oxidative Stress - physiology
phenotype
physiology
prevention & control
Renin-Angiotensin System
Renin-Angiotensin System - physiology
secretion
therapeutic use
Weight Loss
Weight Loss - physiology
ISSN:1467-7881, 1467-789X, 1467-789X
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Obesity‐related hypertension is increasingly recognized as a distinct hypertensive phenotype requiring a modified approach to diagnosis and management. In this review rapidly evolving insights into the complex and interdependent mechanisms linking obesity to hypertension are discussed. Overweight and obesity are associated with adipose tissue dysfunction, characterized by enlarged hypertrophied adipocytes, increased infiltration by macrophages and marked changes in secretion of adipokines and free fatty acids. This results in chronic vascular inflammation, oxidative stress, activation of the renin‐angiotensin‐aldosterone system and sympathetic overdrive, eventually leading to hypertension. These mechanisms may provide novel targets for anti‐hypertensive drug treatment. Recognition of obesity‐related hypertension as a distinct diagnosis enables tailored therapy in clinical practice. This includes lifestyle modification and accommodated choice of blood pressure‐lowering drugs.
Bibliografia:http://dx.doi.org/10.1111/j.1467-789X.2011.00914.x
ark:/67375/WNG-ZN8KC9LZ-2
ArticleID:OBR914
istex:D8616A672EC375FFEBC48974D4D80D7509E6DECA
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
ISSN:1467-7881
1467-789X
1467-789X
DOI:10.1111/j.1467-789X.2011.00914.x